Skip to main content
OpenTrials

Clinical trial condition

Ophthalmoplegia, Chronic Progressive External

Explore clinical trials studying Ophthalmoplegia, Chronic Progressive External. Study availability and eligibility vary by location and protocol.

10 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Ophthalmoplegia, Chronic Progressive External trial results

Recruiting

North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)

NCT01694940

Conditions
Abnormalities, Multiple, Acid-Base Imbalance, Acidosis, +86 more
Locations
  • University of California San Diego San Diego, California, United States
  • Lucile Packard Children's Hospital Stanford, California, United States
  • Children's Hospital of Colorado Aurora, Colorado, United States
  • Children's National Medical Center Washington D.C., District of Columbia, United States
View all 17 locations
View Trial Details
Not yet recruiting

Prospective Natural History Study of POLG Disease

NCT07775872

Conditions
Ataxia, Brain Diseases, Central Nervous System Diseases, +24 more
Locations
  • University of California San Diego San Diego, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Columbia University Irving Medical Center New York, United States
  • Akron Children's Hospital Akron, Ohio, United States
View Trial Details
Completed

Study to Evaluate Efficacy and Safety of Elamipretide in Subjects With Primary Mitochondrial Disease From Nuclear DNA Mutations (nPMD)

NCT05162768

Conditions
Chronic Disease, Cranial Nerve Diseases, Disease Attributes, +26 more
Locations
  • University of California, San Diego San Diego, California, United States
  • Rare Disease Research, LLC Atlanta, Georgia, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View all 32 locations
View Trial Details
Completed

Open-Label, Dose-Escalating Study Assessing Safety, Tolerability, Efficacy, of RP103 in Mitochondrial Disease

NCT02023866

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +40 more
Locations
  • University of California at San Diego (UCSD) San Diego, California, United States
  • Stanford University Stanford, California, United States
  • Akron Children's Hospital Akron, Ohio, United States
  • Baylor College of Medicine Houston, Texas, United States
View Trial Details
Completed

The KHENEREXT Study

NCT04604548

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +35 more
Locations
  • Rigshospitalet, University of Copenhagen Copenhagen, Denmark
  • Klinikum der Universität München Friedrich-Baur-Institut München, Germany
  • Radboud University Medical Center Nijmegen, Netherlands
  • Institute for Ageing and Health Newcastle University Newcastle upon Tyne, United Kingdom
View Trial Details

Related conditions